###begin article-title 0
###xml 0 27 0 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methionine synthase A2756G </italic>
###xml 75 117 75 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase C677T </italic>
Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The association of genetic polymorphisms related to metabolism of homocysteine with inflammatory bowel disease has been evidenced in Crohn disease and remains an open question in ulcerative colitis. We evaluated the association of the polymorphisms of MTHFR, MTR, MTRR and TCN2 genes with ulcerative colitis in Central China.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 4 12 <span type="species:ncbi:9606">patients</span>
168 patients were genotyped for these polymorphisms and compared to 219 matched controls.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methionine synthase </italic>
###xml 274 309 274 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methylenetetrahydrofolate reductase</italic>
###xml 580 615 580 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase</italic>
Methionine synthase 2756G allele frequency was higher in ulcerative colitis than in controls 0.15 (95% C.I. 0.11-0.19) vs 0.09 (95% C.I. 0.07 - 0.12), (P = 0.0137) and predicted ulcerative colitis risk in logistic regression, with an Odds ratio at 1.8 (95% C.I. 1.15-2.84). Methylenetetrahydrofolate reductase 677TT genotype was 2.7-fold more prevalent in individuals with pancolitis than in those with left colitis or proctitis, with respective percentages of 27.3 (95% C.I.16.4-42.0) and 10.5 (95% C.I. 6.3-17.1) (P = 0.0123). The carriage of 677TT or 677CT/1298AC genotypes of methylenetetrahydrofolate reductase was more frequent in cases with pancolitis than in subjects with left colitis or proctitis (P = 0.0048), with an Odds ratio adjusted by age and sex at 3.3 (95% C.I. 1.4-7.9), P = 0.0084) in logistic regression.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methionine synthase </italic>
###xml 24 59 24 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase</italic>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
Methionine synthase and methylenetetrahydrofolate reductase are genes of vitamin B12 and folate cellular metabolism associated respectively with risk and extent of ulcerative colitis, at least in Central China. This finding may open new insights, particularly for the potential interest in treating patients carrying the 677TT MTHFR genetic trait and a deficit in folate.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 319 355 319 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase </italic>
###xml 356 367 356 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T</italic>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 376 396 376 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methionine synthase </italic>
###xml 397 407 397 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR A2756G</italic>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 417 447 417 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methionine synthase reductase </italic>
###xml 448 457 448 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR A66G</italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C677T </italic>
###xml 699 705 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 837 852 837 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">transcobalamin </italic>
###xml 858 868 858 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2 C776G</italic>
###xml 991 992 991 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1155 1156 1155 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Homocysteine is a key metabolite of the one carbone metabolism, at the cross point between the remethylation pathway that produces methionine and the transulfuration pathway that produces cysteine [1]. Plasma homocysteine (t-Hcys) is influenced by genetic polymorphisms of the key enzymes of the remethylation pathway, methylenetetrahydrofolate reductase (MTHFR C677T) [2,3], methionine synthase (MTR A2756G) [4] and methionine synthase reductase (MTRR A66G) [5]. MTHFR catalyses the synthesis of methyletetrahydrofolate, the methyl donor of homocysteine and MTR and MTRR are the two key enzymes of the synthesis of methionine by remethylation of homocysteine. The C677T genetic polymorphism in the MTHFR gene is found to be associated with a thermo-labile variant enzyme that shows a reduced activity [2]. A genetic polymorphism in the transcobalamin gene (TCN2 C776G) is another genetic trait that may influence the vitamin B12 cellular delivery and consequently, homocysteine metabolism [6]. Transcobalamin is a specific plasma transporter of cobalamin (vitamin B12) and facilitates the cellular uptake of the vitamin by receptor-mediated endocytosis [6].
###end p 11
###begin p 12
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677T </italic>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 983 989 983 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1099 1105 1099 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1297 1314 1297 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR, MTR, MTRR </italic>
###xml 1318 1323 1318 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2 </italic>
###xml 1701 1712 1701 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR 677T </italic>
###xml 1746 1751 1746 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2 </italic>
###xml 1859 1861 1859 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1862 1864 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1865 1867 1865 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 690 698 <span type="species:ncbi:9606">patients</span>
###xml 1270 1278 <span type="species:ncbi:9606">patients</span>
Hyperhomocysteinemia is recognized as a risk factor for both venous and arterial thrombosis in the general population [7,8]. In this regard, genetic determinants of homocysteine metabolism have received increasing attention over the past decade as potential contributors to the greater risk of thrombosis in inflammatory bowel disease (IBD) subjects [9]. Homocysteine has also a crucial role in cellular stress, epigenetic events, inflammatory processes and host-microbial interactions. Hyperhomocysteinemia might therefore influence the clinical history of IBD, including disease severity [9]. Mahmud and colleagues were the first to report a higher prevalence of MTHFR 677T allele in IBD patients, compared to controls [10]. Nevertheless a number of subsequent studies have produced conflicting results, possibly related with complex interactions between environmental and genetic factors [11-17]. Ethnic and geographical variations in the distribution and phenotypic influence of MTHFR variants may explain, at least in part, discrepancies between case control studies on the association between MTHFR polymorphism and IBD [18,19]. Polymorphisms of other homocysteine metabolism-related enzymes may also contribute to the link between homocysteine metabolism and IBD patients. The influence of MTHFR, MTR, MTRR and TCN2 polymorphisms on the primary and secondary risk of ulcerative colitis have never been evaluated in a same sample population. Most of the case-control studies have evaluated Caucasian populations from North America and Europe, where the prevalence of Crohn disease is predominant, in contrast with populations from Asia, where UC is the most frequent form of IBD. In contrast to MTHFR 677T allele, the G allele frequency of TCN2 polymorphism is dramatically higher in Central China, compared with that reported in Caucasian populations [16,18,19].
###end p 12
###begin p 13
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2 </italic>
The aim of this study was therefore to evaluate the influence of genetic determinants of homocysteine metabolism, MTHFR, MTR, MTRR and TCN2 with the primary risk and the clinical manifestations of UC, in a case control study of a sample population from Central China.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study subjects
###end title 15
###begin p 16
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
Eligible patients were males or females with established ulcerative colitis UC. 168 patients who were recruited from one single department (Department of Gastroenterology and Reseach center of Digestive diseases, Zhongnan Hospital of Wuhan University, Wuhan, province of Hubei, RP China) were prospectively enrolled in a case-control study, during a 2-years period. Information regarding concomitant medications was collected at study entry. Extent of UC was defined according to Montreal Classification [20]. The term "Pancolitis" means "ulcerative colitis that involves the entire colon." The UC subjects were compared to 219 healthy volunteers from a blood donor Center of Wuhan, who presented without anemia, abdominal pain, inflammation, diarrhea nor blood in the stools. The controls were extracted from a larger cohort and were matched for age and sex with UC patients. All individuals belonged to Han ethnicity and originated from the Hubei province, in Central China. This study was approved by the local ethic committee, and the subjects included gave informed consent, according to the Helsinki declaration.
###end p 16
###begin title 17
Assays and DNA genotyping procedures
###end title 17
###begin p 18
###xml 326 332 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C677T </italic>
###xml 336 343 330 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A1298C </italic>
###xml 360 365 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 382 393 376 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A2756G MTR </italic>
###xml 401 411 395 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A66G MTRR </italic>
###xml 638 640 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 641 643 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 664 675 658 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2 C776G </italic>
###xml 780 781 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 834 839 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 841 845 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 849 854 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
Fasting venous blood was collected in EDTA-containing tubes, immediately centrifuged, and stored at -20degreesC until analysis. DNA was isolated from a lymphocyte-enriched fraction of whole blood with NUCLEON BACC3 for extraction of genomic DNA kit (Amersham Pharmacia Biotech, Milan, Italy). The procedures for detecting the C677T and A1298C polymorphisms of MTHFR, as well as the A2756G MTR and the A66G MTRR polymorphisms, were based on polymerase chain reaction (PCR) amplification, restriction cleavage and separation of the DNA fragments by 15% non denaturant polyacrylamide gel electrophoresis (SDS-PAGE), as previously described [18,19]. Genotyping of the TCN2 C776G polymorphism was performed by the amplification-refractory mutation system, as described recently by us [6]. DNA samples corresponding to amplified DNA of the MTHFR, MTR and MTRR genotypes were sequenced and subsequently used as controls in all series of genotype determination. Five % of the samples were re-genotyped to check for genotype calling consistency, with a genotyping success rate higher than 98%.
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 1395 1397 1386 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1011 1019 <span type="species:ncbi:9606">patients</span>
###xml 1152 1160 <span type="species:ncbi:9606">patients</span>
The tested a priori hypotheses were the association of the genetic determinants of homocysteine metabolism with the primary risk and the clinical characteristics of the disease, respectively. Categorical variables were reported as counts, percentages and 95% confidence interval, and continuous variables as means +/- SD. For categorical variables, continuity-corrected chi-square test or exact Fisher test (when variables were stratified in function of clinical characteristics) were used to assess differences. For continuous variables, a Mann-Whitney U-test was employed. The significance, odds ratios (OR) and 95% confidence interval of independent determinants regarding the risk of IBD were determined by logistic regression analysis using a model that included age, sex and the genetic and clinical variables. The residual model of logistic regression multivariate analysis considered only the variables with P-value < 0.10 in the univariate analysis. The minimal size of our sample was estimated at 150 patients, with a study power 1-beta = 0.8 and alpha = 0.05, assuming a 1.5-fold difference in the less frequent alleles between controls and patients. P-value lower than 0.05 indicated statistical significance and Bonferroni correction for multiple testing was used as described previously, when several dependent or independent statistical tests were being performed simultaneously [18]. (Data were prospectively collected and analyzed using the Statview 5 software for Windows (SAS Institute, Berkley, California, USA) and the SPSS 10.0 software for Windows (SPSS, Paris, France). HWE was tested using the chi-square two-tailed calculation of Knud Christensen, population genetics, www.kursus.kvl.dk.
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of UC patients
###end title 22
###begin p 23
###xml 346 347 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
There were no significant difference in sex ratio between controls and UC patients, with respectively 38% and 42% of females (P = 0.3660); the age was respectively 41 +/- 15 and 41 +/- 12 years (P = 0.7428). The age onset was 38 +/- 15, without difference among gender. The main clinical characteristic of the UC patients are summarized in table 1. A quarter presented with an extensive form of colitis and about 57% with lesions limited to rectum and/or sigmoid. None of the cases presented with a reported thromboembolic episode.
###end p 23
###begin p 24
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Categorical clinical characteristics of the 168 patients with ulcerative colitis.
###end p 24
###begin title 25
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Comparison of the genetic characteristics of UC patients and controls
###end title 25
###begin p 26
###xml 79 98 79 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T, A1298C</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN </italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR</italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN </italic>
###xml 556 567 556 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR 677T </italic>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1298C </italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
There was no linkage desequilibrium among different genotypes. The genotype of MTHFR C677T, A1298C, MTR, MTRR, and TCN could be determined in respectively 215, 213, 218, 219, 216 of the 219 DNA samples from controls and in respectively 168, 160, 156, 164, 146 of the 168 DNA samples from UC cases. The genotype distributions of MTHFR, MTR, MTRR, and TCN polymorphisms of patients were in Hardy-Weinberg equilibrium (P-values of two tailed chi-square 0.5071, 0.8231, 0.3055, 0.7184, 0.4237, respectively) and were not influenced by gender (data not shown). MTHFR 677T and 1298C alleles were in complete disequlibrium, as previously reported in other populations [3].
###end p 26
###begin p 27
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN </italic>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 216 230 216 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR 2756AG/GG </italic>
###xml 423 433 423 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR 2756G </italic>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 538 548 538 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR 2756G </italic>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
The genotype distributions of MTHFR, MTRR and TCN polymorphisms did not differ between controls and UC patients (table 2). The same observation was made for allele frequencies (table 2). In contrast, the carriers of MTR 2756AG/GG genotypes were more frequent in UC than in the control group, with respective percentages of 26.3 (95% C.I. 20.0-33.7) and 16.5 (12.2-22.0) (P = 0.0212). The same observation was made with the MTR 2756G allele frequency, with a difference even more significant (table 2). In logistic regression, carriage of MTR 2756G allele was an independent predictor of UC, with an Odds ratio estimated at 1.8 (table 2).
###end p 27
###begin p 28
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Genotype frequencies and minor allele frequencies of genetic polymorphisms in ulcerative colitis patients and controls.
###end p 28
###begin p 29
*(OR: unadjusted odds ratio; 95 CI%: 95% confidence interval)
###end p 29
###begin p 30
###xml 15 51 15 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase </italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 60 80 60 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methionine synthase </italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 87 123 87 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methylenetetrahydrofolate reductase </italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR</italic>
###xml 134 149 134 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">transcobalamin </italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2</italic>
Abbreviations :methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methylenetetrahydrofolate reductase (MTRR) and transcobalamin (TCN2)
###end p 30
###begin p 31
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
# Dominant genotype. a Comparison with dominant genotype.
###end p 31
###begin title 32
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Association of genetic polymorphisms with clinical characteristics of UC patients
###end title 32
###begin p 33
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN </italic>
###xml 308 320 308 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR 677TT </italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TT </italic>
###xml 397 409 397 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T </italic>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT </italic>
###xml 684 697 684 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677CT/1298AC </italic>
We next examined the association of polymorphisms of homocysteine metabolism-related enzymes with the clinical characteristics. None of the polymorphisms influenced the age onset of the disease. In univariate analysis, MTR, MTRR and TCN polymorphisms were not associated with location and extent of UC while MTHFR 677TT genotype was associated with pancolitis. The frequency of the TT genotype of MTHFR C677T polymorphism was 2.7-fold higher in UC individuals with pancolitis than in other UC cases, with respective percentages of 27.3 (95% C.I.16.4-42.0) and 10.5 (95% C.I. 6.3-17.1) (P = 0.0123). The frequency of subjects who presented with either 677TT or the double heterozygous 677CT/1298AC genotype was also significantly different between subjects with pancolitis and those with left colitis or proctitis, with respective percentages of 43.2 (95% C.I. 29.6-43.2) and 20.2 (95% C.I. 14.1-28.1) (P = 0.0048).
###end p 33
###begin p 34
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 412 425 412 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR 677 TT </italic>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT </italic>
###xml 573 587 573 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C677CT/1298AC </italic>
###xml 600 606 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 617 629 617 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR 677TT </italic>
Finally, the association of gene polymorphisms of genes of the remethylation pathway with the risk of pancolitis was estimated by logistic regression analysis using a model that included age, sex, medications and genetic polymorphisms. We confirmed that the only significant independent gene predictor of extensive lesions was MTHFR. The sex and age adjusted odds ratio of the association between pancolitis and MTHFR 677 TT was estimated to 3.82 (95% C.I. 1.3-11.7, P = 0.0179). When the age and sex adjusted analysis was performed by considering the carriers of 677TT or C677CT/1298AC genotypes of MTHFR instead of MTHFR 677TT only, the same conclusion was reached, with an Odds ratio at 3.3 (95% C.I. 1.4-7.9, P = 0.0084).
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR</italic>
###xml 198 201 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCN2</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 399 405 399 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT </italic>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C677CT</italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1298AC </italic>
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 553 563 553 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR 2756G </italic>
###xml 1146 1147 1146 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1168 1174 1168 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT </italic>
###xml 1178 1191 1178 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1298AC/677CT </italic>
###xml 1270 1271 1270 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1287 1293 1287 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT </italic>
###xml 1305 1311 1305 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1454 1455 1454 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1476 1488 1476 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T </italic>
###xml 1654 1656 1654 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1862 1863 1862 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1864 1866 1864 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1612 1620 <span type="species:ncbi:9606">patients</span>
Genetic factors possibly associated with ulcerative colitis remain poorly known. This is the first study that evaluated the association of genes of the remethylation pathway of homocysteine, MTHFR, MTR, MTRR and TCN2, in a case population restricted to UC, in China. It evidenced a significant association of MTR and MTHFR variants with the primary risk and the extent of the disease, respectively; 677TT and C677CT/1298AC genotypes of MTHFR were predictors of extensive colitis, while no association was found with the primary risk of UC. In contrast, MTR 2756G allele was associated with an increased risk of UC and had no influence on the extent of the disease. MTR and MTFHR have a complementary role in this pathway. During the remethylation of homocysteine into methionine, a methyl group provided by 5-methyltetrahydrofolate (5-methylTHF) is transferred to homocysteine by MTR. In this remethylation pathway, cobalamin (vitamin B12) is involved as an intermediate carrier of the methyl group while the 5-methylTHF is synthesized by MTHFR. The phenotypic influence of the 2756G allele on the activity of MTR has not been clearly evidenced [4]. In contrast, both 677TT and 1298AC/677CT genotypes are known to produce a decreased catalytic enzyme activity of MTHFR [2]. Notably, the 677TT genotype of MTHFR is encoding a thermolabile variant characterized by an alanine to valine substitution at position 222, and a 50% reduction in enzyme activity [2]. As a consequence, MTHFR C677T polymorphism produces a decreased cellular level of methyl-THF and a cellular accumulation of homocysteine, particularly in patients with insufficient folate supply [21]. Interestingly, recent experimental findings raise the possibility that homocysteine-induced cellular and vascular stress may contribute to the maintenance of a chronic mucosal inflammatory state in IBD [9,22].
###end p 36
###begin p 37
###xml 29 41 29 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 808 817 808 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR TT </italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1016 1025 1016 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR 66A </italic>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1571 1573 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1657 1684 1657 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methionine synthase A2756G </italic>
###xml 1944 1946 1944 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1947 1949 1947 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1985 1987 1985 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T </italic>
###xml 2135 2137 2135 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2138 2140 2138 2140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2206 2212 2206 2212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 2430 2436 2430 2436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 2721 2723 2721 2723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2906 2908 2906 2908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3045 3047 3045 3047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3156 3158 3156 3158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 3397 3399 3397 3399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3502 3508 3502 3508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 3662 3664 3662 3664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1035 1043 <span type="species:ncbi:9606">patients</span>
###xml 2711 2719 <span type="species:ncbi:9606">patients</span>
Clinical implications of the MTHFR C677T polymorphism include increased risk for several diseases, such as vascular, neurological and for birth defects [21,23]. Its phenotypic influence on homocysteine metabolism is neutral in subjects with sufficient folate supply, as in South Europe [18]. Similarly, the association of MTHFR with other diseases than IBD seems to be neutral in South European countries, where the status of populations in folate is better than in North Europe, while some studies have showed association with MTR and MTRR in these countries [23,24]. This could explain some of the discrepant results produced on association studies with IBD in populations with contrasted status in folate. Indeed, two studies performed in Northern Europe reported a significant increased frequency of the MTHFR TT genotype [10,25], whereas four studies in Southern Europe (two Italian, one French, one Portuguese) and one Chinese study showed no difference [11,14-17]. In contrast, we found a higher frequency of MTRR 66A allele in patients with Crohn's disease compared with controls, and we observed an influence of this gene variant on the extent of the disease [26]. We also evidenced that vitamin B12 was a nutritional determinant of homocysteinemia, that was under the influence of oxidative stress [26]. Consistently, a recent report showed that folate deficiency was not a predictor of homocysteine level in case of increased oxidative stress, underscoring the implication of other nutritional determinants, such as vitamin B12, under pathological conditions [27]. Taken together, these results are in agreement with our findings indicating that methionine synthase A2756G polymorphism, a vitamin B12-dependent enzyme, may predict ulcerative colitis. The data are also difficult to compare among contrasted populations since the frequency of these gene polymorphisms and their influence on homocysteine fluctuate greatly, worldwide [18,19]. The prevalence of the homozygous T allele seems to be influenced by folate status, the prevalence being the highest in Mexicans, Chinese and Italians and the lowest in West Africans [18,19]. It would be therefore useful to revisit the studies on IBD and MTHFR that have been published in Europe by evaluating also the association with the other gene variants related with the remethylation pathway. Finally, the discrepancies observed in previous studies on association between MTHFR and IBD may also correspond in part to differences in the proportion of cases with extensive colitis, as suggested by our observation that MTFHR is a predictor of pancolitis, at least in UC. This observation was in agreement with our previous study of a smaller series of UC patients [16]. In addition, the association with severity of the disease may be related with a deficit in folate and vitamin B12, as previously observed by us in Caucasians with Crohn's disease [26]. Vitamin B12 metabolism influenced Crohn's disease activity by modulating oxidative stress, measured by superoxide dismutase activity [26]. Homocysteine levels were recently correlated with activity, number of flares and duration of the disease [28]. Unfortunately, we could not determine the blood level of these determinants in the present series as no serum or plasma sample was available. Furthermore, we recently found that azathioprine therapy decreased plasma homocysteine level [26], suggesting interactions between azathioprine and homocysteine metabolisms. Genetic variation in the MTHFR gene may result in reduced S-adenosylmethionine concentations, leading to enhanced TPMT enzyme degradation and possibly modulating azathioprine efficacy [29].
###end p 37
###begin p 38
###xml 47 59 47 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR C677T </italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Over the past decade, hyperhomocysteinemia and MTHFR C677T polymorphism have been regarded solely as potential contributors to the greater risk of thrombosis in IBD [14,15,30-32]. Our data indicated clearly that it influenced the severity of UC, independently of the risk of thrombosis, as none of the case from our series underwent a thrombosis episode.
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR and MTHFR </italic>
###xml 339 351 339 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">677TT MTHFR </italic>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
MTR and MTHFR are two genes of vitamin B12 and folate cellular metabolism associated respectively with the primary risk and the severity of UC, at least in central China. These findings might open new insights into the pathogenesis and assessment of UC, particularly for the potential interest in treating the patients presenting with the 677TT MTHFR genetic trait and a deficit in folate. However, our results await confirmation in a large cohort of patients with UC.
###end p 40
###begin title 41
Competing interests
###end title 41
###begin p 42
The authors declare that they have no competing interests.
###end p 42
###begin title 43
Authors' contributions
###end title 43
###begin p 44
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
J-LG was the guarantor and supervisor of the study. MC, LP-B, BX and J-LG contributed to conception and design, recruitment of patients, analysis and interpretation of data and drafting of the manuscript. R-MG-R carried out the biological and genetics analyses, interpretation of data, statistical analyses, revising of the manuscript. BX and MC recruited the patients and M-AB and J-PB contributed in interpretating the data. LP-B and J-LG revised the manuscript. All authors read and approved the final manuscript.
###end p 44
###begin title 45
Pre-publication history
###end title 45
###begin p 46
The pre-publication history for this paper can be accessed here:
###end p 46
###begin p 47

###end p 47
###begin title 48
Acknowledgements
###end title 48
###begin p 49
Institutional funding was received from Region Lorraine and Inserm (France) and a grant of international collaboration was supported from China Hubei provincial science & technology department (2007CA003). No private sponsor was involved in the study. Min Chen was recipient of a fellowship grant from Chinese service center for scholarly exchange, PR of China, and from Region Lorraine, France.
###end p 49
###begin article-title 50
Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine
###end article-title 50
###begin article-title 51
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 51
###begin article-title 52
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?
###end article-title 52
###begin article-title 53
Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction
###end article-title 53
###begin article-title 54
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria
###end article-title 54
###begin article-title 55
Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood
###end article-title 55
###begin article-title 56
Hyperhomocysteinemia and venous thrombosis: a meta-analysis
###end article-title 56
###begin article-title 57
###xml 102 105 <span type="species:ncbi:9606">men</span>
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
###end article-title 57
###begin article-title 58
Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine
###end article-title 58
###begin article-title 59
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications
###end article-title 59
###begin article-title 60
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease
###end article-title 60
###begin article-title 61
Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study
###end article-title 61
###begin article-title 62
Homocysteine and MTHFR C677T variant in inflammatory bowel disease
###end article-title 62
###begin article-title 63
Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease
###end article-title 63
###begin article-title 64
Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis
###end article-title 64
###begin article-title 65
Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China
###end article-title 65
###begin article-title 66
###xml 59 67 <span type="species:ncbi:9606">patients</span>
High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease
###end article-title 66
###begin article-title 67
Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study among Mexican, West African and West European populations
###end article-title 67
###begin article-title 68
Environmental influence on the world-wide prevalence of a 776C>G variant in the transcobalamin gene (TCN2)
###end article-title 68
###begin article-title 69
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
###end article-title 69
###begin article-title 70
Biological and clinical implications of the MTHFR C677T polymorphism
###end article-title 70
###begin article-title 71
###xml 35 41 <span type="species:ncbi:10090">murine</span>
Antioxidants as novel therapy in a murine model of colitis
###end article-title 71
###begin article-title 72
Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome?
###end article-title 72
###begin article-title 73
Meta-analysis of MTHFR 677C-->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
###end article-title 73
###begin article-title 74
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
###end article-title 74
###begin article-title 75
###xml 91 99 <span type="species:ncbi:9606">Patients</span>
Association of MTRR 66A > G Polymorphism With Superoxide Dismutase and Disease Activity in Patients With Crohn's Disease
###end article-title 75
###begin article-title 76
Folate deficiency and plasma homocysteine during increased oxidative stress
###end article-title 76
###begin article-title 77
Plasma total homocysteine in the active stage of ulcerative colitis
###end article-title 77
###begin article-title 78
Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity
###end article-title 78
###begin article-title 79
###xml 43 51 <span type="species:ncbi:9606">patients</span>
High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
###end article-title 79
###begin article-title 80
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
###end article-title 80
###begin article-title 81
Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens
###end article-title 81

